Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1996
05/23/1996WO1996014864A1 Immunoliposomes that optimize internalization into target cells
05/23/1996WO1996014863A1 Suppression of proteolytic activity by dysfunctional protease formation
05/23/1996WO1996014862A1 Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
05/23/1996WO1996014861A1 Glial derived neurotrophic factor as a neuroprotective agent
05/23/1996WO1996014860A1 Process for identifying para cation channel modulators
05/23/1996WO1996014859A1 Topical preparation
05/23/1996WO1996014858A1 Use of angiotensin ii fragments and analogs thereof in tissue repair
05/23/1996WO1996014857A1 Multicatalytic protease inhibitors
05/23/1996WO1996014856A1 Cancer inhibitory peptides
05/23/1996WO1996014854A1 Treatment of pancreatic tumors with peptide yy and analogs thereof
05/23/1996WO1996014837A1 Gene therapy for hypercholesterolemia
05/23/1996WO1996014836A1 Method and apparatus for gene therapy
05/23/1996WO1996014748A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
05/23/1996WO1996014746A1 A method of inducing resistance to tumor growth
05/23/1996WO1996014744A1 Protective effects of mutated superantigens
05/23/1996WO1996012020A3 Hemoglobin receptors from neisseriae
05/23/1996WO1996009831A3 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards
05/23/1996WO1996009389A3 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein
05/23/1996WO1996009322A3 Synducin mediated modulation of tissue repair
05/23/1996WO1996009066A3 Method of treatment of human immunodeficiency virus (hiv) infection
05/23/1996WO1996007440A3 Methods and apparatus for the delivery of solid drug compositions
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2205138A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996CA2205083A1 Immunogenic compositions
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2204886A1 Amelioration of human erectile dysfunction by treatment with inos, and related nos agents
05/23/1996CA2204871A1 Methods for modulating transcription from the amyloid .beta.-protein precursor (app) promoter
05/23/1996CA2204870A1 Ribozyme analogs
05/23/1996CA2204665A1 Beta3 integrin subunit specific polypeptides, cdnas which encode these polypeptides and methods of producing these polypeptides
05/23/1996CA2204630A1 Regulation of neural stem cell proliferation
05/23/1996CA2204629A1 In vitro induction of dopaminergic cells
05/23/1996CA2204597A1 Suppression of proteolytic activity by dysfunctional protease formation
05/23/1996CA2204379A1 Sensory and motor neuron derived factor (smdf)
05/23/1996CA2203934A1 Targeted t lymphocytes
05/23/1996CA2203654A1 Human stanniocalcin-alpha
05/23/1996CA2203565A1 Synthesis of peptide nucleic acids (pnas) and analogues via submonomer approach
05/23/1996CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996CA2203133A1 Purification of hemoglobin
05/23/1996CA2202760A1 Multicatalytic protease inhibitors
05/22/1996EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
05/22/1996EP0712934A2 Proteins with fibrinolytic and anticoagulant activity
05/22/1996EP0712932A2 A human flavin-containing monooxygenase
05/22/1996EP0712931A2 Interferon-gamma production inducing polypeptide, monoclonal antibody, and agent for interferon-gamma susceptive disease
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712862A2 Selective acylation of epsilon-amino groups
05/22/1996EP0712861A2 Acylated insulin analogs
05/22/1996EP0712632A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
05/22/1996EP0712631A2 Cyclosporin containing multiple emulsions
05/22/1996EP0712389A1 Therapeutic compound - fatty acid conjugates
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/22/1996EP0712312A1 Suppression of inhibitors
05/22/1996EP0712307A1 Methods for b-cell population control
05/22/1996EP0712277A1 Jak kinases and regulation of cytokine signal transduction
05/22/1996EP0521914B1 A method for regulating neuron development and maintenance
05/22/1996EP0506971B1 Peptide with activity of inhibiting phospholipase a2 originating in inflamed part
05/22/1996EP0502081B1 Proliferative action of leukaemia inhibitory factor on satellite cells
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/22/1996CN1123038A Antisense oligonucleotides which combat aberrant splicing and methods of using the same
05/22/1996CN1122717A Improved thrombin compound
05/22/1996CN1122690A Polypeptide protein micro-beads medicine prepn. method
05/21/1996US5519120 Urokinase-type plasminogen activator receptor antibodies
05/21/1996US5519119 Muteins of TNF pharmaceutical compositions and a method of making
05/21/1996US5519118 Human MDM2 protein involved in human tumors
05/21/1996US5519117 Polypeptide sequences as anticarcinogenic agents
05/21/1996US5519116 Peptides representing permutations of the mastoparan sequence
05/21/1996US5519115 Reverse antimicrobial peptides
05/21/1996US5519114 Retroviral superantigens, superantigen peptides, and methods of use
05/21/1996US5519042 Method of treating hyperproliferative vascular disease
05/21/1996US5519005 Guanidine terminated peptides for treatment of thrombosis, antitumor agents, autoimmune diseases and immunology
05/21/1996US5519002 Lutenizing hormone releasing hormone and an immunogenic conjugate
05/21/1996US5519001 CETP inhibitor polypeptide antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
05/21/1996US5519000 Tumor necrosis factor inhibitors
05/21/1996US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability
05/21/1996US5518998 Therapeutic preparation for inhalation
05/21/1996US5518916 Cloned Babesia DNA
05/21/1996US5518911 Human PAK65
05/21/1996US5518899 Propagation with polypeptides and carbohydrates for treatment of viricides
05/21/1996US5518889 Immunoassay methods using single polypeptide chain binding molecules
05/21/1996US5518888 Imaging metastasized colorectal cancer, toxtin peptides less than 25 units
05/21/1996US5518735 Anticoagulants administered by mouth
05/21/1996US5518724 Infectious bursal disease virus
05/21/1996US5518721 Anticaries agents
05/21/1996US5518720 Monoclonal antibody
05/21/1996CA1338344C Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
05/19/1996CA2163136A1 Human flavin-containing monooxygenase
05/18/1996CA2162986A1 Proteins having fibrinolytic and coagulation-inhibiting properties
05/17/1996WO1996014420A1 Inducible cell ablation
05/17/1996WO1996014418A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996WO1996014413A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
05/17/1996WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR
05/17/1996WO1996014411A1 Methods for the diagnosis of glaucoma
05/17/1996WO1996014410A1 Human scf, a splice variant thereof, its pharmaceutical use
05/17/1996WO1996014409A1 Production of recombinant peptides as natural hydrophobic peptide analogues
05/17/1996WO1996014407A1 Recombinant alternaria alternata allergens
05/17/1996WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996WO1996014398A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014394A1 Human dna ligase iii
1 ... 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 ... 3163